To study the comparison of efficacy and side effect profile of bimatoprost 0.03% versus fixed combination timolol 0.5% and dorzolamide 2% in patients with primary open angle glaucoma or ocular hypertension

Journal Title: Indian Journal of Clinical and Experimental Ophthalmology - Year 2016, Vol 2, Issue 3

Abstract

Aims: To study IOP lowering efficacy and side effect profile of bimatoprost 0.03% versus fixed combination timolol 0.5% and dorzolamide 2%. Settings and Design: Prospective, open, randomized, parallel group, comparative study, 100 patients of POAG/ocular hypertension with moderate glaucomatous damage attending the outpatient department of ophthalmology, at our institute were included. Materials and Methods: The patients were randomly assigned to one of the two treatment groups, each having a sample size of 50 patients. Group 1 instilled 1 drop of Bimatoprost 0.03%at 8 p.m. (once daily) for 12 weeks and Group 2 instilled 1 drop of fixed drug combination of timolol 0.5% and dorzolamide 2% at 8a.m. and 1 drop at 8p.m. for 12 weeks. All the patients were subjected to the detailed ocular examination following examination and tests at baseline, 4 weeks, 8 weeks and 12 weeks after starting the study treatment. Results: Both the groups showed comparable IOP reductions in the patients. There was no statistically significant difference in the mean IOP reduction among the two groups’ at all follow-up visits. The most frequently reported adverse effect was conjunctival hyperaemia in bimatoprost group and burning, stinging sensation in eyes and taste perversion in the DTFC group. Conclusion: Bimatoprost can be used as a long term monotherapy agent in the treatment of POAG and ocular hypertension providing good efficacy with an easy dosing regimen and without much side effects.

Authors and Affiliations

Ramandeep Kaur, Sachin Walia, Harsimran Singh, Navreet Kaur

Keywords

Related Articles

Socio-demographic determinants of glaucoma medications compliance: A North Indian cross sectional study

ntroduction: To investigate the level of compliance with glaucoma medications in a clinical setting of a tertiary north Indian hospital amongst both rural and urban patients and the factors associated with failed complia...

Pediatric cataract blindness management and outcomes in North East India – hospital based study

Purpose: To study the visual outcomes and cause of poor visual prognosis in pediatric cataract patients in North East India. Methods: Retrospective analyses of 283 eyes of patients with cataract below age of 18 years wit...

Inter ocular variability of common glaucoma parameters in patients with primary open angle glaucoma

Aim: To assess the intrasubject variability of CCT,IOP and VCDR in patients with POAG compared to normal. Design: Cross sectional study. Materials and Methods: A total of 100 eyes of patients on treatment for POAG and 10...

Nd-YAG laser posterior capsulotomy and visual outcome

Introduction: Posterior capsular opacification is the most common delayed complication of cataract surgery with IOL implantation. This results due to proliferation and migration of reminant epithelial cells that form clu...

Correlation study of modifiable risk factors and age related Maculopathy

Aim and Objective: To study relationship between ARMD and risk factors. Methodology: A total sample size of 4000 patients above 60 years attending ophthalmology OPD of center were enrolled in the study. The data collecti...

Download PDF file
  • EP ID EP241220
  • DOI -
  • Views 83
  • Downloads 0

How To Cite

Ramandeep Kaur, Sachin Walia, Harsimran Singh, Navreet Kaur (2016). To study the comparison of efficacy and side effect profile of bimatoprost 0.03% versus fixed combination timolol 0.5% and dorzolamide 2% in patients with primary open angle glaucoma or ocular hypertension. Indian Journal of Clinical and Experimental Ophthalmology, 2(3), 174-177. https://europub.co.uk/articles/-A-241220